Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor A...
Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658-62)
About this item
Full title
Author / Creator
Publisher
Sŏul: Korean Diabetes Association / Daehan Dangnyobyeong Hakoe
Journal title
Language
English
Formats
Publication information
Publisher
Sŏul: Korean Diabetes Association / Daehan Dangnyobyeong Hakoe
Subjects
More information
Scope and Contents
Contents
[...]Dr. Kawada suggested undertaking a multiple regression analysis stratified by sex and the presentation of squared values of multiple regression coefficients (R2). [...]Dr. Kawada proposed a discussion regarding the cardiovascular benefits of the combination of SGLT2 inhibitor and GLP-1 receptor agonist. NOTES CONFLICTS OF INTEREST No potential...
Alternative Titles
Full title
Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658-62)
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_10028768
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_10028768
Other Identifiers
ISSN
2233-6079
E-ISSN
2233-6087
DOI
10.4093/dmj.2022.0166
